This website uses cookies
Read our Privacy policy and Terms of use for more information.
Where AI, patient data and societal shifts change portfolio, launch and roadmap decisions, and where they don't. Written by Aditi Sharma, founder of Talon Group Consulting, who advises senior leaders at global biopharma, medtech and life science tools companies. New issues every week.
Subscribe here: